hide message

Welcome to the Resource Centre

We make it our mission to work with advocates in civil society, business and government to address inequalities of power, seek remedy for abuse, and ensure protection of people and planet.

Both companies and impacted communities thank us for the resources and support we provide.

This is only possible because of your support. Please make a donation today.

Thank you,
Phil Bloomer, Executive Director

Donate now hide message

Pharma cos join research institutions to speed up discovery of essential new treatments for TB

Author: Pharmabiz.com, Published on: 26 June 2012

Seven pharmaceutical companies and four research institutions…have entered into a partnership to speed up the discovery of essential new treatments for tuberculosis (TB). [T]he TB Drug Accelerator (TBDA) [partnership], will target the discovery of new TB drugs by collaborating on early-stage research…Abbott, AstraZeneca, Bayer, Eli Lilly, GlaxoSmithKline, Merck and Sanofi will open up targeted sections of their compound libraries and share data with each other and four research institutions…Breaking from traditional...practices, the companies will work together to develop the best prospects, regardless of where the drug originated. The structures of lead compounds identified through the program will ultimately be placed in the public domain...Tuberculosis…is the second leading infectious cause of death worldwide, having killed nearly 1.4 million people in 2010 alone…

Read the full post here

Related companies: Abbott Laboratories AstraZeneca Bayer Eli Lilly GlaxoSmithKline Merck Sanofi Sanofi Pasteur (part of Sanofi)